Evaluation of metabolic control using a continuous subcutaneous glucose monitoring system in patients with type 1 diabetes mellitus who achieved insulin independence after islet cell transplantation.

Cell Transplant 2005 ;14(2-3):77-84

Diabetes Research Institute, University of Miami School of Medicine, Miami, FL 33136, USA.

This study evaluated the Medtronic MiniMed Continuous Glucose Monitoring System (CGMS) in patients with type 1 diabetes mellitus who underwent successful islet cell transplantation (ICT). The results are compared to standardized self-monitoring (SMBG) of hyperglycemia and mean amplitude of glycemic excursions (MAGE). We studied 19 patients (mean age 40.0 +/- 6.7 years) in three groups: six patients post-ICT, seven patients awaiting ICT, and six normal volunteers (controls). Continuous glucose monitoring post-ICT showed remarkable glucose stability compared with patients awaiting ICT. The CGMS group showed modestly higher glucoses (mean 111.5 mg/dl) compared with controls (88 mg/dl). Postprandial glucoses in ICT recipients rarely exceeded 180 mg/dl and were similar to controls. There was no difference in asymptomatic hypoglycemia between control and post-ICT groups. However, a higher incidence of hypoglycemia was observed in patients awaiting ICT. HbA1c and MAGE pre- and post-ICT were 8.3 +/- 0.9% and 6 +/- 0.3% (p < 0.001) and 109 +/- 34 and 41 +/- 11 (p < 0.001), respectively. No complications were associated with CGMS. This study suggests ICT significantly improves metabolic control and rate of hypoglycemia when compared with controls and patients awaiting ICT. Similar improvement in metabolic control was observed with SMBG, HbA1c, and MAGE. Although CGMS was not demonstrated to be a superior tool for routine assessment in ICT, it is very helpful in special clinical situations.

Download full-text PDF

Source
http://dx.doi.org/10.3727/000000005783983214DOI Listing
August 2005
18 Reads

Publication Analysis

Top Keywords

awaiting ict
16
patients awaiting
16
glucose monitoring
12
metabolic control
12
type diabetes
8
monitoring system
8
patients
8
compared controls
8
cell transplantation
8
diabetes mellitus
8
islet cell
8
ict
8
hba1c mage
8
continuous glucose
8
patients type
8
+/-
5
180 mg/dl
4
exceeded 180
4
recipients rarely
4
glucoses ict
4

References

(Supplied by CrossRef)

Alejandro R. et al.
Cell Transplant. 2003

Alejandro R. et al.
Diabetes 1997

Argiard F. et al.
Transplantation 1980

Boland E. et al.
Diabetes Care 2001

Brendel M. D. et al.
Newsletter 9 2001

Chase H. P. et al.
Pediatrics 2001

Diabetes Control and Complications Trial Research Group. et al.
N. Engl. J. Med. 1993

Gores P. F. et al.
Lancet 1993

Goss J. A. et al.
Transplantation 2002

Similar Publications